Denosurel 120 mg Injection 1.7 ml contains ‘denosumab’, which works by blocking a receptor in the body which causes bone loss, thereby treats bone loss. Denosurel 120 mg Injection 1.7 ml treats giant cell tumour of bone (GCTB) by blocking certain receptors in the tumour cells, thereby slows the tumour growth. Denosurel 120 mg Injection 1.7 ml helps treat high calcium levels by decreasing bone breakdown as a breakdown of the bones releases calcium. Denosurel 120 mg Injection 1.7 ml makes the bones stronger and less likely to break. Denosurel 120 mg Injection 1.7 ml will be administered by a healthcare professional; do not self-administer. You are advised to take Denosurel 120 mg Injection 1.7 ml for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as bone/joint/muscle pain, arm/leg pain, abdominal discomfort, constipation, and painful/frequent urination. You are advised to talk to your doctor if you experience these side effects persistently. Denosurel 120 mg Injection 1.7 ml might cause osteonecrosis of the jaw; therefore, whilst on treatment with Denosurel 120 mg Injection 1.7 ml, maintain good dental hygiene and receive regular dental check-ups. Avoid taking Denosurel 120 mg Injection 1.7 ml if you are pregnant. Consult your doctor before taking Denosurel 120 mg Injection 1.7 ml if you are breastfeeding. Denosurel 120 mg Injection 1.7 ml is not recommended for children below 18years as safety and effectiveness have not been established. Keep your doctor informed about your health condition and medicines to rule out any side effects.